RxDoctor Payments DataLook up a doctor →

PLUVICTO: payments to doctors

Payments that named PLUVICTO as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$130.1M
Providers
11,816
Transactions
37,582
Average per transaction
$3,462

The per-transaction average — $3,462 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 11,816 providers the average total is $11,012, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Advanced Accelerator Applications$128,333,12698.6%
Novartis$1,775,9461.4%
Novartis Pharma AG$9,1500.0%
← All drugs & devices